Eif6-flox 基因敲除小鼠

1. Koh, Ai Ling, Bonnard, Carine, Binte Ali, Nur Ain, Reversade, Bruno, Jamuar, Saumya. 2021. Heterozygous Missense Variant in EIF6 gene: a novel form of Shwachman-Diamond Syndrome? In American journal of medical genetics. Part A, 188, 384. doi:10.1002/ajmg.a.62498. https://pubmed.ncbi.nlm.nih.gov/34528395/

2. Wang, Zhenzhen, Yang, Shuai, Tong, Linglin, Zhang, He, Chen, Renjin. 2024. eIF6 deficiency regulates gut microbiota, decreases systemic inflammation, and alleviates atherosclerosis. In mSystems, 9, e0059524. doi:10.1128/msystems.00595-24. https://pubmed.ncbi.nlm.nih.gov/39225466/

3. Zhang, Fangyingnan, Waheed, Saquib, Armato, Ubaldo, Zhang, Chao, Li, Zhibin. 2022. eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma. In Frontiers in oncology, 12, 848346. doi:10.3389/fonc.2022.848346. https://pubmed.ncbi.nlm.nih.gov/35707354/

4. Sun, Liping, Liu, Shuguang, Wang, Xiaopai, Chen, Ya, Shen, Hong. 2021. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway. In Journal of translational medicine, 19, 216. doi:10.1186/s12967-021-02877-4. https://pubmed.ncbi.nlm.nih.gov/34016142/

5. Gao, Yan, Yuan, Lingling, Zeng, Jing, Ke, Changbin, Pei, Zhijun. 2022. eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma. In Journal of translational medicine, 20, 303. doi:10.1186/s12967-022-03503-7. https://pubmed.ncbi.nlm.nih.gov/35794622/